https://de.marketscreener.com/kurs/aktie/NERVGEN-PHARMA-CORP-55763923/news/NervGen-Pharma-Corp-plant-den-Beginn-einer-neuen-Studie-in-der-Probanden-Open-Label-Nvg-291-absolv-45982182/?utm_source=telegram&utm_medium=social&utm_campaign=share